key: cord-0731570-x0tlbo1y authors: Gungor, Serap; Tosun, Betul; Unal, Nursemin; Dusak, Ismail title: Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus date: 2021-07-20 journal: Int J Clin Pract DOI: 10.1111/ijcp.14631 sha: b39a3367bda39564630f0029d9e206166c6709fb doc_id: 731570 cord_uid: x0tlbo1y AIM: Dyspnea, a common symptom of novel coronavirus, can negatively affect sleep quality. The aim of this study was to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID‐19. STUDY DESIGN: A cross‐sectional design was used. METHODS: Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The data‐collection form comprised three parts: a patient descriptive information form, the Dyspnea–12 Questionnaire, and the Richards–Campbell Sleep Questionnaire (RCSQ). RESULTS: The mean age of patients was 46.39 ± 12.61 years and 66.0% were men. Patients who were treated in the intensive care unit had bachelor's degree or more and patients with comorbid diseases had low mean scores from the RCSQ and high mean scores from the Dyspnea–12 Questionnaire (P < .001, P < .001; P = .047, P < .001; P < .001, P < .001, respectively). Patients who were not receiving oxygen therapy had higher RCSQ mean scores and lower Dyspnea–12 Questionnaire scores (P < .001, P < .001; P < .001, P < .001, respectively). There was a strong negative relationship between the total scores obtained from the RCSQ and the Dyspnea–12 Questionnaire (r = −.701, P < .001). CONCLUSIONS: Sleep quality is affected by dyspnea severity in patients with COVID‐19. Sleep quality and dyspnea severity are also influenced by quite different factors, and these should be addressed and eliminated by nurses as part of a holistic approach. The results of this study will help nurses, especially those providing treatment and care for patients with COVID‐19, to identify the factors affecting dyspnea and sleep quality and to plan, implement and evaluate nursing interventions that will reduce their workload. Dyspnea, a symptom seen in about 40% of patients, negatively affects quality of life by causing difficulty performing daily life activities as a result of sleep problems, increased care dependency, depression and anxiety. 4, 5 Sudden or severe dyspnea in COVID-19 patients causes an increase in lung lesions, leading to further aggravation of the disease. 6 About 50% of COVID-19 patients with severe dyspnea have acute respiratory distress syndrome (ARDS), difficult-to-correct metabolic acidosis and coagulopathy, and a number of these may die in the first week after disease onset. 7 New infectious diseases like severe acute respiratory syndrome (SARS) and COVID-19 affect patients not only physically but also psychologically, causing anxiety, depression and sleep disorders in the treatment process. 6, 8 Sleep not only affects quality of life but also plays a role in preserving immune function and reducing the transmission of viral infections; it is also vital to maintaining mental well-being. 8, 9 A decrease in sleep quality increases dyspnea by exacerbating pre-existing hypoxemia and hypercapnia, thereby increasing the patient's anxiety and depression levels. 10 In the COVID-19 treatment process, patients are isolated, typically in intensive care units (ICUs). 6, 11 Lai et al (2020) 12 reported that isolated individuals experienced high levels of depression, anxiety and stress; insomnia; and a decrease in their sleep quality. The required treatment of this highly contagious disease means that being alone for an extended time in a room increases these symptoms. 13 To provide personal and quality patient care and to manage dyspnea effectively, nurses should rate dyspnea severity and measure sleep quality in each COVID-19-positive patient and focus on the affecting factors. The aim of this study is to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. This study was conducted to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. What is the severity of dyspnea in patients with COVID-19? How is the sleep quality of patients with COVID- 19? Is there a relationship between dyspnea severity and sleep quality in patients with COVID-19? This is a descriptive and cross-sectional study. Participants in this study were adult patients who were diagnosed with COVID-19 and received inpatient treatment in a training and research hospital. The population of this study was N = 122 patients. A total of 100 volunteer patients who met the following criteria participated: being in a COVID-19 clinic or in second-line intensive care where patients with COVID-19 were being treated between 1 and 30 June 2020; having spent at least one night in the hospital; being conscious (with a Glasgow Coma Scale score of 13 or above); being able to communicate verbally; having complained of dyspnea; and having no obstacles to participating in the study in terms of the treatment process. The presence of dyspnea, which is one of the inclusion criteria, was asked to the patients as "Have you ever had trouble in breathing after being diagnosed with COVID-19"? in the patient descriptive information form. Patients who stated that they had respiratory distress were included in the study. Also, researchers checked the oxygen saturation levels of the patients and patients with oxygen saturation below 90% once from the date of patient admission were included in the study. Since COVID-19 is a new epidemic disease that first appeared in December 2019, there is, to the best of our knowledge, no study to date that has examined the relationship between dyspnea and sleep quality in patients with COVID-19. With no prior study to reference for calculating the sample, a power analysis of the study was performed with 100 patients by taking into consideration the number of questionnaire items. In a power analysis performed with a sample What's known • New infectious disease COVID-19 affects patients not only physically but also psychologically, causing anxiety, depression, and sleep disorders in the treatment process. • Sleep not only affects quality of life but also plays a role in preserving immune function and reducing the transmission of viral infections; it is also vital to maintaining mental well-being. • About 50% of COVID-19 patients with severe dyspnea have acute respiratory distress syndrome. • Patients with COVID-19 were found to suffer from poor sleep quality, and the more severe patients' dyspnea was, the lower their sleep quality was. • Dyspnea and sleep quality were affected by many factors in the pandemic survey. • Elderly patients, patients with a comorbid disease, smokers, those who received continuous or intermittent oxygen therapy using non-invasive CPAP masks, and those hospitalized in the ICU had more severe dyspnea. size of 100 patients, the correlation between the Richards-Campbell Sleep Questionnaire (RCSQ) and the Dyspnea-12 Questionnaire was calculated as r = .0703; the effect size is 0.83; and the power of the study is 90% with a confidence interval of 95%. The data-collection form comprised three parts: a patient descriptive information form, the Dyspnea-12 Questionnaire and the RCSQ. Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The researcher visited the clinic and intensive care unit, using personal protective equipment between 09.00 and 12.00 am After informing the patients face to face, the researcher collected the data with an online questionnaire. The researcher informed the patients about the study after taking appropriate preventive measures and maintaining social distance. A link was sent to those patients who agreed to participate via an instant messaging application, and they completed the questionnaire in about 10-15 minutes after selecting the option "I was informed of and agree to participate in the study." The patient descriptive information form, the first part of the data-collection process, was developed by the researchers based on the literature review and included the following: gender, date of birth, educational level, name of clinic where the individual was admitted, the presence of any comorbid diseases, financial status, smoking status, whether the patient was receiving oxygen support therapy and, if so, which type, sleep habits, and whether the patient felt rested upon awakening. 6, [14] [15] [16] The same treatment protocol were applied to patients who received COVID-19 treatment. In this scope, the following drugs were given to the patients: if breathing is exhausting. The remaining five items of the questionnaire focus on the affective aspects of breathing such as depression, misery, distress, agitation, and irritation. The maximum scores for the physical and affective aspects of the questionnaire are 21 and 15, respectively. The minimum total score for the questionnaire is 0, whereas the maximum total score is 36. The higher the score, the more severe the dyspnea. The original study reported the Cronbach's alpha of this questionnaire as 0.90. 17 The adaptation of the Dyspnea-12 Questionnaire to Turkish and validity and reliability studies were conducted by Gok Metin and Helvacı, 16 who found Cronbach's alpha to be 0.97. In this study, Cronbach's alpha was found to be 0.99. The RCSQ is a six-item questionnaire that assesses the depth of night sleep, sleep onset latency, frequency of awakenings, time spent awake after waking up, sleep quality and level of ambient noise. Scores in the range of 0-25 refer to "very poor sleep" and 76-100 to "very good sleep". Although, there is no cut-off value for poor and good, it was stated that the higher the score, the higher the sleep quality. 18 The adaptation of the RCSQ to Turkish and its validity and reliability studies were conducted by Ozlu and Ozer, 19 and Cronbach's alpha was found to be 0.91, showing that the RCSQ is a highly reliable questionnaire with internal consistency. In this study, Cronbach's alpha was found to be 0.93. The data were analyzed using SPSS 22 Statistics software package. 20 Number, mean, standard deviation, minimum, maximum, and frequency were used in the descriptive statistical analyses in the study. The data were tested for normal distribution using the Shapiro-Wilk test and skewness and kurtosis values. Student's t test, one-way ANOVA and Kruskal-Wallis tests were used to compare the questionnaire mean scores of two independent groups and three or more groups, respectively. Bonferroni correction was applied to determine which group caused the difference in the three-group comparison. To clarify which group caused the difference, the statistically significant differences were indicated in the tables using the superscripts "a, b, c, d" and codes such as "a-b, c" when three or more groups were compared. For example, the code "a-b, c" means that there is a statistically significant difference between the variable "a" and the variables "b" and "c" but no statistically significant difference between "b" and "c." The relationships between the total score for the RCSQ and the total score for the Dyspnea-12 Questionnaire and its sub-dimensions (physical and affective) were determined using the Pearson correlation analysis. The statistical significance was set at P < .05 in all tests. The study was initiated after receiving approval from the local eth- This study was completed with 100 patients diagnosed as COVID- Those patients being treated in the ICU had a significantly lower RCSQ mean total score than those being treated in the clinic (t = −7.591, P < .001), and illiterate patients had a significantly lower RCSQ mean total score than those having a bachelor's degree or higher (f = 2.741, P < .047). Furthermore, the RCSQ mean total score of those who did not have a comorbid disease was significantly higher than those who had one (t = 3.88, P < .001); the RCSQ mean total score of those who could communicate with their family by phone was significantly higher than for those who could not (t = −5.949, P < .001); the RCSQ mean total score of those who reached the nurses by using the call button was significantly higher than those who called out to them (t = 2.309, P < .023). The RCSQ mean total score of the patients who did not receive oxygen therapy was significantly higher than for those who received continuous and intermittent oxygen therapy (f = 33.862, P < .001) and those who received oxygen therapy via nasal cannula, simple mask, and noninvasive continuous positive airway pressure (CPAP) (f = 25.638, P < .001) ( Table 2 ). The patients in the ICU (t = 10.373, P <.001), those in the age group 65 years and older (t = 2.847, P < .05), and those with comorbid diseases (t = −7.119, P < .001) had a statistically significantly higher mean total score on the Dyspnea-12 Questionnaire. It was found that the dyspnea scale was affected by the smoking status, and the difference was because of the difference in mean scores between smokers and non-smokers (X 2 = 10.798, P = .005). Furthermore, it was found that dyspnea severity varied depending on educational status, with those having a bachelor's degree or higher having a lower mean total score on the Dyspnea-12 Questionnaire than those who were unable to read or write and those who were primary-school graduates (f = −6.260, P < .001). When the Dyspnea-12 Questionnaire mean scores of the patients were compared in regard to the type and frequency of oxygen therapy, it was found that those who did not receive oxygen therapy had a significantly lower score than those receiving it either continuously or intermittently (f = 70.912, P < .001) and those receiving it via nasal cannula, simple mask, and non-invasive CPAP. Moreover, those who received oxygen therapy using non-invasive CPAP had a significantly lower score than those receiving it via nasal cannula and simple mask (f = 115.074, P < .001). No statistically significant differences were found between the mean total scores obtained from the RCSQ in terms of gender, age, smoking status and financial status (P > .05) ( Table 3) . There was a statistically significant strong negative correlation between the total score for the Richards-Campbell Sleep Questionnaire and the total score for the Dyspnea-12 Questionnaire and its sub-dimensions (physical and affective) (r = −0.701, P < .001). It was also found that the higher the patients' dyspnea severity was, the lower their sleep quality was (Table 4 ). In this study, which was conducted to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19, it was found that, among those patients whose sleep quality was poor, the more severe their dyspnea was, the lower their sleep quality was. In the previous studies, dyspnea was defined as "the permanent and progressive airflow limitation occurring as a result of the inflammatory response in the lungs". and reported to be associated with numerous symptoms including cough, fatigue, sleep problems, anxiety and depression. 10, 11, 21 In this study, more than half of the patients with COVID-19 were found to be men with comorbid diseases such as diabetes mellitus, chronic obstructive pulmonary disease (COPD), and hypertension. Thus, it can be hypothesized that the presence of a comorbid disease generally exacerbates patients' COVID-19 symptoms, leading to hospitalization for treatment. A similar patient population was reported in studies conducted in China, 22 the US 23 and India. 24 In the present study, more than half of the patients (60.0%) were non-smokers, and the majority of smokers quit smoking during this period, which aligned with the results of otherstudies. 25, 26 While most of the patients were treated in the clinical services, those who were older were treated in the ICUs. The previous studies also reported that the majority of the patients were treated in clinics, Abbreviations: COPD, chronic obstructive pulmonary disease, CPAP, continuous positive airway pressure. *Options were multipy (participants may have more than one comorbid disease). and older, those who needed oxygen support, and those who received intensive care treatment had more-severe dyspnea since they had more-severe respiratory system-related symptoms of COVID-19. In this study, a strong negative correlation was found between the total scores obtained from the RCSQ and those obtained from the Dyspnea-12 Questionnaire and its subquestionnaires. This means that patients with COVID-19 who have a high level of dyspnea also suffer from low-quality sleep. Ora et al 38 The authors declare that they have no conflict of interest. Abbreviations: t, independent two-sample t test; f, single directional variance analysis; X 2 , Kruskal-Wallis test. *Statistical significance at P < .05. **The difference between the groups expressed by the letters is statistically significant at P < .05 after Bonferroni correction. ***Statistical significance at P < .001. participants had to fill to agree that they understood and volunteered to participate. Data available on request because of privacy/ethical restrictions. WHO announces COVID-19 outbreak a pandemic Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Greater dyspnea is associated with lower health-related quality of life among european patients with COPD Prevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five european countries Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis İnterpretation of" guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5 Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China Chronobiology international is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination The relationship between sleep quality, anxiety and depression in patients with chronic obstructive pulmonary disease An early study on intelligent analysis of speech under COVID-19: severity, sleep quality, fatigue, and anxiety Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019 Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR Clinical characteristics of 138 hospitalized patients with 2019 Novel coronavirus-infected pneumonia in Wuhan retrospective study Validity and reliability of Turkish version of the Dyspnea-12 Scale Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea12 Measurement of sleep in critically ill patients Richard-Campbell sleep questionnaire validity and reliability study SPSS 22 Statistics Symptom cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and metaanalysis Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical characteristics of coronavirus disease 2019 in China The convergence study on anxiety, knowledge, infection possibility, preventive possibility and preventive behavior level of MERS in nursing students Changes in sleep pattern, sense of time and digital media use during COVID-19 lockdown in Italy The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey Evaluation of sleep related breathing disorders and obstructive sleep apne syndrome in interstitial lung patients The impact of COPD on health status: findings from the BOLD study Assessment of health-related quality of life in different phenotypes of COPD Prevalence of dyspnea and its associated factors in patients with chronic obstructive pulmonary disease The Relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Smoking duration, respiratory symptoms, and COPD in adults aged 3 45 years with a smoking history Global Strategy for the Diagnosis, Management and Preventing of Chronic Obstructive Pulmonary Disease Dyspnea perception and neurological symptoms in non-severe COVID-19 patients Psychological distress and sleep quality of COVID-19 patients in Wuhan, a lockdown city as the epicenter of COVID-19 Insomnia in patients with COPD Sleep in chronic obstructivepulmonary disease: evidence gaps and challenges Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus